Health economic evaluation of therapeutic strategies in patients with idiopathic achalasia: Results of a randomized trial comparing pneumatic dilatation with laparoscopic cardiomyotomy

Surgical Endoscopy and Other Interventional Techniques

Volumn 21, Issue 7, 2007, Pages 1184-1189

  Kostic, S ^a   Johnsson, E ^b   Kjellin, A ^c   Ruth, M ^b   Lonroth H ^b   Andersson, M ^b   Lundell, L ^c  

^a BORÅS HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Achalasia; Balloon dilatation; Health economic evaluation; Laparoscopy; Myotomy; Symptoms; Treatment failure

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COURSE EVALUATION; ESOPHAGUS ACHALASIA; ESOPHAGUS DILATATION; ESOPHAGUS MYOTOMY; ESOPHAGUS PERFORATION; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PNEUMATIC TOOL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STOMACH FUNDOPLICATION; SURGICAL PATIENT; TREATMENT FAILURE;

ADULT; AGED; BALLOON DILATATION; COST-BENEFIT ANALYSIS; ESOPHAGEAL ACHALASIA; ESOPHAGOSCOPY; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SWEDEN; TREATMENT OUTCOME;

EID: 34347398658     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-007-9310-0     Document Type: Article

References (30)

1. Sonnenberg A, Massey BT, McCarty DJ, Jacobsen SJ (1993) Epidemiology of hospitalisation for achalasia in the United States. Dig Dis Sci 38:233-244
2. Mayberry JF, Atkinson M (1987) Variations in the prevalence of achalasia in Great Britain and Ireland: an epidemiological study based on hospital admissions. Q J Med 62:67-74
3. Howard PJ, Maher L, Pryde A, Cameron EW, Heading RC (1992) Five years prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 33:1011-1015
4. Ben-Meir A, Urbach DR, Khajanchee YS, Hansen PD, Swanstrom LL (2001) Quality of life before and after laparoscopic Heller myotomy for achalasia. Am J Surg 181:471-474
5. Urbach DR, Tomlinson GA, Harnish JL, Martino R, Diamant NE (2005) A measure of disease-specific health related quality of life for achalasia. Am J Gastroenterol 100:1668-1676
6. Spiess AE, Kahrilas PJ (1998) Treating achalasia: from whalebone to laparoscope. JAMA 280:638-642
7. Abir F, Modlin I, Kidd M, Bell R (2004) Surgical treatment of achalasia: current status and controversies. Dig Surg 21:165-176
8. Vantrappen G, Hellemans J, Deloof W, Valembois P, Vandenbroucke J (1971) Treatment of achalasia with pneumatic dilatations. Gut 121:268-275
9. Bonavina L, Nosadini A, Bardini R, Baessato M, Peracchia A (1992) Primary treatment of esophageal achalasia. Long-term results of myotomy and Dor fundoplication. Arch Surg 127:222-226
10. Patti MG, Fisichella PM, Perretta S, Galvani C, Gorodner MV, Robinson T, Way LW (2003) Impact of minimally invasive surgery on the treatment of esophageal achalasia: a decade of change. J Am Coll Surg 196:698-703
11. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I (1996) Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 221:8-13
12. Dimenas E (1993) Methological aspects of evaluation of quality of life in upper gastrointestinal diseases. Scan J Gastroenterol Suppl 199:18-21
13. Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27(Suppl):217-232
14. Dupuy HJ (1984) The Psychological General Well-Being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CF (eds) Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. LeJacq Publishing Inc., New York, pp 170-183
15. Svedlund J, Sjödin I, Dotevall G (1988) GSRS: a clinical rating scale for gastrointestinal symtoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129-134
16. Svedlund J, Sullivan M, Sjodin I, Liedman B, Lundell L (1996) Quality of life in gastric cancer prior to gastrectomy. Qual Life Res 5:255-264
17. Korolija D, Sauerland S, Wood-Dauphinee S, Abbou CC, Eypasch E, Gareia Caballero M, Lumsden MA, Millat B, Monson JRT, Nilsson G, Pointer R, Schwenk W, Shamiyeh A, Szold A, Targarona E, Ure B, Neugebauer E (2004) Surg Endosc 18:879-897
18. Parkman HP, Reynolds JC, Ouyang A, Rosato EF, Eisenberg JM, Cohen S (1993) Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig Dis Sci 38:75-85
19. O'Connor JB, Singer ME, Imperiale TF, Vaezi MF, Richter JE (2002) The cost-effectiveness of treatment strategies for achalasia. Dig Dis Sci 47:1516-1525
20. Imperiale TF, O'Connor JB, Vaezi MF, Richter JE (2000) A cost-minimization analysis of alternative treatment strategies for achalasia. Am J Gastroenterol 95:2737-2745
21. Draaisma WA, Buskens E, Bais JE, Simmermacher RK, Rijnhart-de Jong HG, Broeders IA, Gooszen HG (2006) Randomized clinical trial and follow-up study of cost-effectiveness of laparoscopic versus conventional Nissen fundoplication. Br J Surg 93:690-697
22. Myrvold HE, Lundell L, Miettinen P, Pedersen SA, Liedman B, Hatlebakk J, Julkunen R, Levander K, Lamm M, Mattson C, Carlsson J, Stahlhammar NO (2001) The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut 49:488-494
23. van Hout BA, Al MJ, Gordon GS, Rutten FF (1994) Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 3:309-319
24. Weinstein MC, Stason WB (1977) Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296:716-721
25. Brauer CA, Rosen AB, Greenberg D, Neumann PJ (2006) Trends in the measurement of health utilities in published cost-utility analyses. Value Health 4:213-218
26. Richards KF, Fisher KS, Flores JH, Christensen BJ (1996) Laparoscopic Nissen fundoplication: cost, morbidity, and outcome compared with open surgery. Surg Laparosc Endosc 6:140-143
27. Romagnuolo J, Meier MA, Sadowski DC (2002) Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model. Ann Surg 236:191-202
28. Van Den Boom G, Go PM, Hameeteman W, Dallemagne B, Ament AJ (1996) Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 31:1-9
29. Csendes A, Braghetto I, Burdiles P, Korn O, Csendes P, Henriquez A (2006) Very late results of esophagomyotomy for patients with achalasia. Ann Surg 243:196-203
30. Csendes A, Braghetto I, Henriquez A, Cortes C (1989) Late results of a prospective randomised study comparing forceful dilatation and esophagomyotomy in patients with achalasia of the esophagus. Gut 30:299-300